Line Uhrenholt

Medicin og biovidenskab

1. Abatacept 28%
2. Ankylosing Spondylitis 16%
3. Anti-Citrullinated Protein Antibodies 6%
4. Antirheumatic Agents 100%
5. Arthritis 45%
6. Baths 14%
7. Certolizumab Pegol 25%
8. Clinical Trials 25%
9. Cohort Studies 26%
10. Confidence Intervals 32%
11. Cross-Over Studies 70%
12. Denmark 57%
13. Equipment and Supplies 20%
14. Ethics Committees 5%
15. Fatigue 11%
16. Global Health 18%
17. Glucocorticoids 6%
18. Hospitalization 28%
19. Incidence 18%
20. Infections 5%
21. Libraries 5%
22. Meta-Analysis 28%
23. Minimal Clinically Important Difference 7%
24. Odds Ratio 24%
25. Outpatients 11%
26. Pain Measurement 13%
27. Pandemics 40%
28. Patient Isolation 54%
29. Patient Reported Outcome Measures 89%
30. Population 6%
31. Psoriatic Arthritis 56%
32. PubMed 5%
33. Quality of Life 5%
34. Randomized Controlled Trials 33%
35. Research Personnel 26%
36. Rheumatic Diseases 82%
37. Rheumatoid Arthritis 99%
38. Rheumatology 7%
39. Smartphone 46%
40. Systematic Reviews 28%
41. Systemic Lupus Erythematosus 36%
42. Therapeutics 6%
43. tocilizumab 22%
44. Vasculitis 7%